Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Scyx 7158
2. Scyx-7158
3. Scyx7158
1. 1266084-51-8
2. Scyx-7158
3. 4-fluoro-n-(1-hydroxy-3,3-dimethyl-1,3-dihydrobenzo[c][1,2]oxaborol-6-yl)-2-(trifluoromethyl)benzamide
4. 2ior2oo3gw
5. 4-fluoro-n-(1-hydroxy-3,3-dimethyl-2,1-benzoxaborol-6-yl)-2-(trifluoromethyl)benzamide
6. 4-fluoro-n-(1-hydroxy-3,3-dimethyl-1,3-dihydro-benzo(c)(1),(2)oxaborol-6-yl-2-trifluoromethyl Benzamide
7. Benzamide, N-(1,3-dihydro-1-hydroxy-3,3-dimethyl-2,1-benzoxaborol-6-yl)-4-fluoro-2-(trifluoromethyl)-
8. Unii-2ior2oo3gw
9. Acoziborole [inn]
10. Acoziborole [who-dd]
11. Schembl1164186
12. Chembl2347704
13. Sctx-7158
14. Chebi:183111
15. Dtxsid301336035
16. An5568
17. Mfcd30532746
18. Akos037644970
19. Db13086
20. 4-fluoro-n-(1-hydroxy-3,3-dimethyl-1,3-dihydro-2,1-benzoxaborol-6-yl)-2-(trifluoromethyl)benzamide
21. Ac-36374
22. As-55745
23. Hy-19910
24. Cs-0016944
25. J3.511.276f
26. W19688
27. A937430
28. Q27254793
29. 4-luoro-n-(1-hydroxy-3,3-dimethyl-2,1-benzoxaborol-6-yl)-2-(triluoromethyl)benzamide
30. 4-fluoro-n-(1-hydroxy-3,3-dimethyl-1,3-dihydro-benzo[c][1,2]oxaborol-6-yl)-2-trifluoromethyl Benzamide
31. N-(1,3-dihydro-1-hydroxy-3,3-dimethyl-2,1-benzoxaborol-6-yl)-4-fluoro-2-(trifluoromethyl)benzamide
| Molecular Weight | 367.1 g/mol |
|---|---|
| Molecular Formula | C17H14BF4NO3 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 7 |
| Rotatable Bond Count | 2 |
| Exact Mass | 367.1002861 g/mol |
| Monoisotopic Mass | 367.1002861 g/mol |
| Topological Polar Surface Area | 58.6 Ų |
| Heavy Atom Count | 26 |
| Formal Charge | 0 |
| Complexity | 545 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
A Acoziborole manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Acoziborole, including repackagers and relabelers. The FDA regulates Acoziborole manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Acoziborole API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Acoziborole supplier is an individual or a company that provides Acoziborole active pharmaceutical ingredient (API) or Acoziborole finished formulations upon request. The Acoziborole suppliers may include Acoziborole API manufacturers, exporters, distributors and traders.
Acoziborole Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Acoziborole GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Acoziborole GMP manufacturer or Acoziborole GMP API supplier for your needs.
A Acoziborole CoA (Certificate of Analysis) is a formal document that attests to Acoziborole's compliance with Acoziborole specifications and serves as a tool for batch-level quality control.
Acoziborole CoA mostly includes findings from lab analyses of a specific batch. For each Acoziborole CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Acoziborole may be tested according to a variety of international standards, such as European Pharmacopoeia (Acoziborole EP), Acoziborole JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Acoziborole USP).
LOOKING FOR A SUPPLIER?
